Quick Links

Physicians’ Education Resource®, LLC, is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.


PER Pulse™ Recaps highlight key elements of the Medical Crossfire®: Optimizing Treatment and Management of Soft Tissue Sarcoma in Community Oncology online CME activity.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Lilly.

For further information concerning Lilly grant funding visit

Medical Crossfire®: Optimizing Treatment and Management of Soft Tissue Sarcoma in Community Oncology

Release Date: November 30, 2016
Expiration Date: November 30, 2017
Media: Internet - based


Activity Overview

This edition of Medical Crossfire® provides community oncologists with evidence-based perspectives on the rationale for current standards of care in soft tissue sarcoma (STS), clinical questions and challenges, and how to integrate optimal approaches into clinical practice. It is designed to update practitioners on advances in the field and focuses on the appropriate diagnosis of STS, multi-disciplinary management, use of new agents, and the value of appropriate referral to a sarcoma specialist under a collaborative-care model. Our program chair, George Demetri, MD, leads the program faculty, Mark Agulnik, MD, Shreyaskumar R. Patel, MD, and Richard F. Riedel in extensive panel discussions on 3 key topics. Throughout the activity, interactive online questions are posted to participants to assess their knowledge and facilitate self-assessment.

CME/CE Activity Table of Contents

  • Introduction
    George D. Demetri, MD
  • Module I: Tackling Clinical Challenges
    Faculty Panel 
  • Module II: Current Strategies Employed in the Management of Unresectable STS in Multiple Lines of Therapy
    Faculty Panel 
  • Module III: Emerging Strategies
    Faculty Panel 
  • Key Take-Aways
    Faculty Panel 
  • Posttest


Requirements for Successful Completion

  • Once you begin the activity, please answer the demographic questions. This will allow you to proceed to the activity.
  • This activity contains one or more interactive questions. You may move forward through the activity; however, you may not go back to change answers or review content until you finish the activity.
  • At the end of the activity, an “Educational Content” link will be available for you to download content in PDF format for your reference.
  • If you close the Web browser after you complete the activity, the Educational Content link will disappear and you will need to review the activity in its entirety to once again access the link.
  • In order to receive a CME certificate, participants must complete the activity.
  • Click on the “Request Credits” link at the end of the activity. Complete the posttest and pass with a score of 70% or higher, complete the evaluation, and then click on request for credit. Participants may immediately download a CME certificate upon completion of these steps.

Participants may immediately download a CME certificate upon completion of these steps.

Target Audience

This educational program is directed toward medical oncologists, surgical oncologists, and radiation oncologists in the treatment of soft tissue sarcoma. Nurse practitioners, physician assistants, nurses, and other healthcare professionals involved in the treatment and management of patients with sarcoma will be invited to participate.

Educational Objectives

  • Explain disease heterogeneity in advanced soft tissue sarcomas (STS) and its impact on treatment strategies and methods to overcome challenges to optimized diagnoses in the field
  • Discuss novel mechanistic approaches for the care of patients with metastatic or unresectable STS
  • Integrate a multimodal approach that engages community-based oncologists to communicate with sarcoma specialists to manage multimodality sequencing in multiple lines of care for patients with STS

Faculty, Staff, and Planners' Disclosures

Program Chair

George D. Demetri, MD
Professor of Medicine, Harvard Medical School
Director, Ludwig Center at Harvard
Director, Center for Sarcoma and Bone Oncology
Dana-Farber Cancer Institute
Boston MA
Disclosure: Grant/Research Support: Bayer, Novartis, Pfizer, Janssen Oncology; Consultant: Novartis, Pfizer, EMD Serono, Sanofi Oncology, Janssen Oncology, PharmaMar, Daiichi-Sankyo, Adaptimmune, Eisai, Blueprint Medicines, Kolltan Pharmaceuticals, Caris Life Sciences.


Mark Agulnik, MD
Associate Professor, Medicine, Hematology Oncology Division
Feinberg School of Medicine
Northwestern Memorial Hospital
Chicago, IL
Disclosure: Speaker’s Bureau: Novartis, Janssen, Eisai.


Shreyaskumar R. Patel, MD
Robert R. Herring Distinguished Professor of Medicine
Center Medical Director, Sarcoma Center
Deputy Chairman, Dept. of Sarcoma Medical Oncology
The University of Texas M.D. Anderson Cancer Center
Houston, TX
Disclosure: Grant/Research Support: Janssen, Eisai, Morphotek; Consultant: Novartis, Janssen, Eisai, EMD- Serono, CytRx, Bayer, Lilly.


Richard F. Riedel, MD
Associate Professor, Division of Medical Oncology
Associate Director, Clinical Research, Duke Sarcoma Program
Associate Program Director, Heme-Onc Fellowship Program
Medical Director, Solid Tumor Inpatient Service
Duke University Health System
Durham, NC
Disclosure: Grant/Research Support: Immune Design, Novartis, Lilly, Aadi Shakti, Karyopharm, Plexxikon, Merck, Tracon Threshold, Tokalas; Consultant: Lilly, EMD-Serono.


Off-Label Disclosure and Disclaimer

This CME activity may or may not discuss investigational, unapproved, or off-label uses of drugs. Participants are advised to consult prescribing information for any products discussed. The information provided in this CME activity is for continuing medical education purposes only and is not meant to substitute for the independent medical judgment of a physician relative to diagnostic and treatment options for a specific patient’s medical condition.
The opinions expressed in the content are solely those of the individual faculty members and do not reflect those of Physicians’ Education Resource®, LLC, or any of the companies that provided commercial support for this activity.

CME Provider Contact Information

Physicians’ Education Resource®, LLC
666 Plainsboro Road, Suite 356
Plainsboro, NJ 08536
Toll Free: 888-949-0045
Local: 609-378-3701
Fax: 609-257-0705

Hardware And Software Requirements 

Supported Browsers
Internet Explorer v.7 or greater (for Windows) | Mozilla Firefox v.2 or greater (for Windows, Mac, Linux)

Minimum System Requirements (Windows)
  • A Pentium-based PC or compatible computer
  • At least 64MB of RAM
  • Windows 95/98/NT/ME/2000/XP/Vista system software
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise
Minimum System Requirements (Mac OS)
  • A PowerPC processor-based Macintosh computer
  • At least 64MB of RAM
  • Mac OS 7.5 or later
  • Screen resolution of 1024 x 786 or larger recommended
  • PDF Reader: Adobe Reader 5.0 or higher, Foxit Reader 2.0 or likewise

Become a Member

Forgot Password?
Calendar of Events
Filter By